Posts

Breakthrough in organic semiconductor synthesis paves t...

A team of researchers led by Professor Young S. Park at UNIST’s Department of Ch...

Korean Artificial Sun, KSTAR, installation of a tungst...

The Korean artificial sun, KSTAR, has completed divertor upgrades, allowing it t...

Revolutionary nanodrones enable targeted cancer treatment

A groundbreaking study led by Professor Sebyung Kang and Professor Sung Ho Park ...

Mettl3-dependent m6A modification is essential for effe...

This study is led by Dr. Shuyang Yu (College of Biological Sciences, China Agric...

MSK research highlights, December 29, 2023

New research from Memorial Sloan Kettering Cancer Center (MSK) developed CAR T c...

Novel solution for Pichia pastoris enzyme production pl...

The demand for industrial enzymes is continually rising, driven by the growing n...

Artificial design and biosynthesis of a single-domain c...

This study is led by Prof. Wen-Bin Zhang (College of Chemistry and Molecular Eng...

Advances and challenges in semantic communications: A s...

This study is led by Prof. Ping Zhang, Dr. Yiming Liu, Yile Song, and Jiaxiang Z...

Molecules exhibit non-reciprocal interactions without e...

Researchers from the University of Maine and Penn State discovered that molecule...

Bristol Myers Squibb agrees to acquire RPT company Rayz...

Bristol Myers Squibb (BMS) has signed a definitive agreement for the acquisition...

Difficult biotech investment ecosystem forces focus on ...

In 2023, investors pursued pharmaceutical assets with value amidst an unstable e...

BMS bags UK advanced melanoma win for Opdualag

The MHRA gave Bristol Myers Squibb’s Opdualag marketing authorisation for advanc...

J&J jumps on ADC train, signs $1.7bn licensing deal wit...

J&J has acquired a global license for South Korean LegoChem’s ADC for $100m upfr...

Elpiscience and Astellas partner for new macrophage eng...

Elpiscience Biopharma has signed an agreement with Astellas Pharma for two new b...

ARTBIO divulges plans for proprietary isotope manufactu...

ARTBIO is developing a proprietary radiotherapy manufacturing technology to over...

AstraZeneca buys Chinese CAR-T biotech Gracell in a $1....

The deal is worth approximately $1.2bn in combined upfront and potential conting...